Onartuzumab
Chemical compound / From Wikipedia, the free encyclopedia
Onartuzumab is a humanized monoclonal antibody designed for the treatment of advanced non-small-cell lung cancer.[1][2][3]
Quick Facts Monoclonal antibody, Type ...
Monoclonal antibody | |
---|---|
Type | Fab fragment |
Source | Humanized (from mouse) |
Target | scatter factor receptor kinase |
Clinical data | |
ATC code |
|
Identifiers | |
CAS Number | |
ChemSpider |
|
UNII | |
Chemical and physical data | |
Formula | C4422H6820N1168O1363S31 |
Molar mass | 99147.88 g·mol−1 |
![]() ![]() |
Close
Onartuzumab was developed by Genentech, Inc. It is undergoing clinical trials.[4][5][6][7]